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Abstract 
Objective: To determine the patient-perceived value of MTM services and non-financial barriers preventing patients with insurance 
coverage from receiving MTM services.  Design: Focus groups. Setting: Fairview Pharmacy Services, Minneapolis, MN. 
Participants: Three focus groups, each with five to nine participants, consisting of different participant populations: (i) patients who 
paid out-of-pocket to receive MTM services; (ii) insurance beneficiaries, under which MTM is a covered benefit and participants may 
have received incentives for receiving MTM services; (iii) patients with an insurance plan which covers MTM services who were 
recruited to receive MTM services but declined.  Intervention: MTM services.  Main Outcome Measure: Patient-perceived value of 
MTM services and non-financial barriers.  Results: Seven themes were identified relating to the patient-perceived value of MTM 
services:  collaboration of the health care team, MTM pharmacist as a supporter/advocate/confidant, MTM pharmacist as a resource 
for questions and education, accessibility to the MTM pharmacist, financial incentives for participation in MTM services, MTM 
pharmacy as a specialty field, and the MTM pharmacist as a coordinator.  Three themes were identified regarding patient-perceived 
non-financial barriers to receiving MTM services, including: availability of the MTM pharmacist, patient/physician lack of knowledge 
of MTM services, patient’s belief that MTM services are not needed.  Conclusion: MTM is a service which patients identify as 
valuable.  Patients are able to identify non-financial barriers that may prevent some patients from receiving MTM services.  This 
study provides preliminary evidence of both the value and barriers perceived by patients. 
 
 
Introduction 
While data illustrating the clinical, economic, and humanistic 
benefits of MTM services is robust, literature surrounding 
patient perceptions of MTM services is lacking.
1 - 7 Although 
some literature analyzes patient perceptions of MTM 
services, the studies are survey-based or completed in 
patients who never personally participated in or declined 
receiving MTM services.
  One aspect of identifying the patient 
perceived value of MTM services lies in determining whether 
or not patients are willing to pay for the service.  One study 
indicated that over 50% of patients are willing to pay for 
MTM services.
8   However, very few of the subjects were 
receiving MTM services at the time of the study.  The author 
states, “Once they actually begin receiving this type of care 
and all of the theoretical benefits that accompany it, it would 
be logical to predict that the value they place on MTM 
services would increase.”
8 Two studies examining patient  
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perceptions of MTM services in community pharmacies have 
been completed in the Medicare Part D population.
9,10  One 
study was completed prior to the implementation of 
Medicare Part D.
9  The purpose was to serve as a baseline for 
patients who had not participated in MTM services.  Study 
participants completed an internet-based survey evaluating 
their attitudes toward pharmacist-provided services under 
the Medicare Part D prescription drug benefit.  The study 
identified two subgroups of patients who had more favorable 
attitudes regarding MTM services: patients who had recently 
visited a physician for an adverse drug event, and patients 
who used clinic pharmacies to fill their prescriptions. The 
researchers recommended that MTM pharmacists target 
these two patient populations for recruitment purposes.
9 
Another study determined that 92.5% of survey respondents 
were not familiar with the terms Medication Therapy 
Management or MTM.
10 After being educated about MTM, 
70% responded that they did not need MTM services, and 
66% reported they would not pay for MTM.  The researchers 
determined that insurance coverage did not affect interest to 
participate in or willingness to pay for MTM services.
10 
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Other studies have examined methods to market MTM 
services.
11 Although researchers primarily investigated 
marketing techniques, there was a small segment of the 
study that addressed the perceived benefits of MTM services 
and potential reasons for not participating.  The participants 
had never received MTM services or declined participation in 
MTM services.  Participants were taught about MTM services 
and then participated in a focus group.  Participants identified 
that MTM services would be beneficial for obtaining 
information about medications and other health concerns, to 
gain assurance that they were doing things correctly, and 
receive the expert opinion of a pharmacist.  Some 
participants felt that participation in MTM services would 
allow for improved communication between pharmacists and 
other health care providers.  The primary barrier to receiving 
MTM services identified by participants was inability to afford 
an MTM visit.  Other barriers identified included lack of time 
for an appointment and access to an MTM pharmacist, and 
fears that information given by the pharmacist would 
contradict recommendations given by their physician.  Most 
participants felt that MTM services should be offered as a 
benefit under their insurance plan.
11 
 
The goal of another study was to examine the perceptions 
that pharmacists have of patients, the perception that 
patients have of pharmacists, and whether patients who 
receive MTM services are more likely to find them 
beneficial.
12   Pharmacists rated MTM services as potentially 
more beneficial than patients did, believing the most 
beneficial services would be to explain to patients how to use 
their medications and to make sure that the patients 
understood the information presented.  Patients rated 
making sure they understood the information as most 
beneficial and being told about other medications which may 
cause problems with the patient’s current medications the 
second most important.  Overall, pharmacists and patients 
disagreed on how beneficial pharmacy services would be for 
the patient.  Pharmacists also misunderstood patients’ 
perceptions on the benefit of MTM services.
12   
 
There are gaps in the literature regarding the patient-
perceived value of MTM services with data gathered from 
patients who have received MTM services or have declined 
participation.  Finally, none of the available literature has 
allowed patients who have received MTM services or 
declined participation to have an open forum for discussion 
as they might have in focus groups.  
     
Setting 
Fairview Health Services, in partnership with the University of 
Minnesota, consists of 7 hospitals and 48 primary care clinics 
throughout the state of Minnesota.  Fairview Pharmacy 
Services, a subsidiary of Fairview Health Services, started 
developing MTM sites in 1997.  Fairview Pharmacy Services 
currently has 17 pharmacists and 2 pharmacy residents 
providing MTM services in 21 ambulatory care clinics.  All of 
the MTM pharmacists at Fairview Pharmacy Services practice 
under the philosophy and patient care process of 
pharmaceutical care.
13   All MTM pharmacists are certified in 
pharmaceutical care by the Peters Institute of Pharmaceutical 
Care at the University of Minnesota and are credentialed by 
Fairview Pharmacy Services.  MTM pharmacists within 
Fairview Pharmacy Services practice under a collaborative 
practice agreement that allows them to initiate, modify, or 
discontinue drug therapy and order laboratory tests for 
multiple medical conditions. 
 
Fairview Pharmacy Services is currently receiving 
reimbursement for MTM services provided to the following 
groups of patients: (i) Minnesota Medicaid beneficiaries 
taking four or more medications to treat two or more chronic 
conditions; (ii) patients enrolled with Medicare Part D plan 
sponsors contracted with Fairview; (iii) beneficiaries of one of 
eight contracted employer groups; and (iv) private paying 
patients.  The eligibility criteria to receive MTM services vary 
for Medicare Part D plan sponsors and employer groups.  
Some employer groups offer incentives such as reduced co-
pays or co-pay waivers for prescriptions.  The cost of each 
MTM visit depends on either the complexity of the patient or 
time spent with the patient, depending on payer 
requirements.   
 
Objectives 
The primary objective of this study is to determine the 
patient-perceived value of MTM services.  The secondary 
objective is to determine non-financial barriers preventing 
patients who have insurance coverage from receiving MTM 
services.   
 
Methods 
This manuscript reports data from three focus groups held in 
March and April 2011.  Focus groups consisted of participants 
from different patient populations:  (i) patients who paid out-
of-pocket to receive MTM services (private payment for MTM 
group), (ii) Minnesota Medicaid beneficiaries, under which 
MTM is a covered benefit, and employees of Fairview or the 
University of Minnesota, in whom MTM is a covered benefit 
and participants may have received incentives for receiving 
MTM services (third party payment for MTM group) and (iii) 
patients with an insurance plan which covers MTM services 
who were recruited via handouts, mailings, or telephone calls 
but declined receiving MTM services (non-participating 
group).   
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The University of Minnesota Institutional Review Board 
reviewed this study and considered it exempt from 
committee review.  Informed consent was obtained from 
participants at the beginning of each focus group session. 
 
Participant Selection   
Fifty patients from each pre-defined group were randomly 
selected for invitation to participate in one of the three focus 
groups with the goal of having six to ten participants per 
focus group.  Potential participants were selected from a pool 
of all patients who have utilized MTM services and those who 
have specifically been recruited for MTM services but 
declined.  Invitation was sent by mail and included a 
description of the study, details regarding time, place, and 
location of the focus group, and information regarding the 
honorarium for participation.  Interested participants were 
asked to RSVP to the principal investigator via telephone or 
email.  Letters were mailed to additional possible participants 
if six to eight participants did not respond from the initial 
mailings (Figure 1).    
 
Focus Group Design 
Each focus group lasted ninety minutes and was facilitated by 
the principal investigator.  Audio was recorded during each 
session.  Focus group participants were provided with dinner 
and a $50 gift card to a local retailer to compensate for their 
time.  
 
The first two focus group sessions consisted of patients who 
had received MTM services from a Fairview MTM pharmacist: 
the private payment group and the third party payment 
group.  Participants in these two focus group sessions were 
asked to reflect upon and discuss the following questions: (i) 
Describe why you decided to have an MTM visit with a 
pharmacist.  What motivated you?  (ii) What benefits did you 
expect from MTM prior to your visit with your pharmacist?  
What benefits did you identify after your visit?  (iii) What 
barriers, if any, did you encounter in the process of receiving 
MTM services?  (iv) Describe your experience, both positive 
and negative.  (v) How did your feelings about MTM change 
following your visit?  (vi) How would you describe MTM to 
your friends and family?  (vii) How should MTM services be 
marketed to patients? 
 
Participants in the third focus group session, the non-
participating group, had never received MTM services.  
Participants in this session were asked to respond to the 
following questions:  (i) Describe why you decided to decline 
having an MTM visit with a pharmacist?  What motivated you 
to make this decision?  (ii) What benefits would you have 
expected from an MTM visit with a pharmacist?  (iii) What 
barriers, if any, did you encounter in the process of receiving 
MTM services?  (iv)  What would make you want to receive 
MTM services?  (v) How would you describe MTM to friends 
and family?  (vi)  How should MTM services be marketed to 
patients?   
 
Demographic information for focus group participants is 
included in Figure 2.  This study was not intended to compare 
characteristics between the three groups.  
 
Data Analysis 
Following completion of each focus group, the principal 
investigator transcribed the audio recordings verbatim into a 
Microsoft® Word document.  Thematic analysis of the session 
was performed according to the steps outlined by Krueger, 
Casey, and Morgan.
14,15  Validation was completed between 
the groups to identify themes consistent across the three 
groups.  Transcripts were read multiple times and analyzed by 
the principal investigator and another member of the 
research team (DRO).  The main emergent themes were 
identified, extracted, discussed and agreed upon. Participant 
statements referring to each particular theme were grouped, 
further explored, and compared with initial key ideas.
16   
Interpretations were discussed among all study investigators.   
 
Results 
The findings from the focus groups are presented for the two 
areas explored in this study, patient-perceived value of MTM 
services and non-financial barriers preventing patients who 
have an insurance plan that covers MTM from receiving MTM 
services. 
 
1. Patient-perceived Value of MTM Services 
Most focus group participants who had received MTM 
services spoke very highly of their experience, identifying 
several areas of value from receiving MTM services.   
 
1.1 “A pharmacist is just part of my team”: Collaboration of 
the Healthcare Team 
The first theme identified as a value from receiving MTM 
services was the collaboration of their health care team. 
“…for me one of the biggest benefits...it’s a 
collaboration…I feel like it’s not just one person or I 
have to go see five different people to figure it out, 
it’s one group and they’re all kind of on the same 
page.” 
 
Not only did focus group participants recognize their personal 
benefits of having an interdisciplinary health care team, but 
they also recognized the benefits to professional members 
within the team, such as reduced stress and more effective 
care.  While several focus group participants felt strongly 
connected with their health care team, others did not and Original Research  PRACTICE-BASED RESEARCH 
 
http://z.umn.edu/INNOVATIONS                        2012, Vol. 3, No. 4, Article 96                          INNOVATIONS in pharmacy    4 
 
mentioned they would like to see more visible collaboration 
amongst their health care professionals.   
 
1.2  “My MTM pharmacist is an advocate for wellness”: 
MTM Pharmacist as Supporter/Advocate/Confidant 
Focus group participants identified their MTM pharmacist as 
a supporter, advocate, and confidant. 
“…the whole pharmaceutical industry is driving at 
sickness and treating sickness.  And I see the MTM 
pharmacist as instead not trying to treat your illness 
but trying to help you get to wellness.” 
 
They appreciated having a health care professional they could 
depend on and lean on if necessary. 
“It makes me feel like there’s actually somebody 
working with me instead of against me…it’s kind of a 
nice feeling.” 
 
 Several focus group participants mentioned difficult 
situations they did not feel they would have overcome 
without the support of their MTM pharmacist.   
 
1.3  “You hope you learn something new that you didn’t 
know before”: MTM Pharmacist as a Resource for Questions 
and Education 
Focus group participants identified several areas where MTM 
pharmacists had played or could play a unique role in 
education and as a resource.  
 “I don’t know how I would have figured out how to 
brush my teeth or wash my face or use skin cream or 
makeup or anything if [the MTM pharmacist] hadn’t 
have researched my allergies.” 
 
From uncommon allergies to drug interactions between 
prescriptions, herbals, and supplements, focus group 
participants saw MTM pharmacists best suited to answer 
those questions.   
 
1.4   “Doctors just don’t have the time to go over 
[medications] in detail.”: Accessibility to the MTM 
Pharmacist 
According to participants in the focus groups, patients highly 
value the time their pharmacists dedicate to them. They 
appreciate the amount of time MTM pharmacists are able to 
spend with patients, especially in comparison to physician 
visits.  
  “[My MTM Pharmacist] took her time…the 
physicians usually come into the room, look at their 
wrist watch to see when they can get out.” 
 
Moreover, a large area of discussion and an area of value the 
focus group participants identified was the easy accessibility 
to their MTM pharmacist, and as a result, their care team.  
Several participants noted similar MTM services offered 
telephonically, but overall the group preferred an initial face-
to-face visit to establish a relationship, with the option of 
follow-up via telephone at later dates.  The focus group 
participants enjoyed the ability to call or email their MTM 
pharmacist and receive timely responses.   
 
1.5  “MTM services could potentially be a lifesaver or a 
money saver…or both.”: Financial Benefits from 
Participation in MTM Services 
While several participants who had received financial 
incentives for participation in MTM services identified that as 
a value to them, participants who did not receive financial 
incentives also identified financial benefits for participation in 
MTM services, such as it being a covered benefit for them, 
identifying cost-saving opportunities with their pharmacist, 
and promoting overall health care savings.    
“[My MTM pharmacist] says, we could do this but 
it’s going to cost more for you or less for you.  And 
then I had a choice so I felt like I had more control…” 
 
1.6 “You get all this specialized information that you 
wouldn’t get from your general practitioner doctor”: MTM 
Pharmacy as a specialty field 
Several participants made reference to seeing specialists, and 
thought MTM pharmacy should be thought of in the same 
way. 
“[Pharmacy] is so complicated and there’s so much 
stuff in everything…that is a field of itself.” 
 
Several participants indicated concern over the prescribing 
habits and knowledge of their own physicians and felt they 
would get an unbiased view from an MTM pharmacist.   
 
1.7. “I have so many –ologists I can’t keep my medications 
all straight”: The MTM pharmacist as a coordinator 
Several participants discussed receiving prescriptions from 
multiple physicians, and their associated fears.  They 
identified concerns and the feeling that their physicians do 
not always review prescriptions prescribed by other 
physicians or take an overall view at their medications. 
“It was nice to think that [my MTM pharmacist] sat 
down and looked at all [the medications] and said 
this is what I think you should do and what would 
work best for all the medications involved.” 
 
The participants took comfort in the fact that the MTM 
pharmacist reviewed and discussed all medications with the 
patient and also sent reports to all of their physicians. 
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2. Non-financial Barriers Preventing Patients from Receiving 
MTM Services 
The focus group participants also identified several barriers 
they encountered in the process of receiving or being 
recruited to receive MTM services.  Focus group participants 
who had received MTM services, as well as those who 
declined, were able to identify non-financial barriers to 
receiving MTM services.  
 
2.1  “[There is no] time to fit it into your schedule”: The lack 
of availability of MTM pharmacists 
Several focus group participants identified that it was difficult 
to schedule appointments with their MTM pharmacist 
because the hours the MTM pharmacist was in the clinic were 
the same as their own personal work hours. 
 “… [it’s difficult for] people who work during the day 
and can’t get off to access this kind of information.” 
 
One participant also identified that her MTM pharmacist was 
only in the clinic a few days a week, making it difficult to see 
her MTM pharmacist on the same days as her physician if she 
wanted to do so.  Other focus group participants mentioned 
the time getting to and from the appointment was a barrier 
for them, as it was more time away from work.   
 
2.2  “I didn’t avail myself of that opportunity because I 
didn’t know what the MTM pharmacist did”: The lack of 
knowledge of MTM services 
Several participants indicated that MTM services are difficult 
to explain without actually receiving the service. 
             “You couldn’t really explain it without experiencing it.” 
 
 Others noted their physician referred them to see the MTM 
pharmacist, but did not do a sufficient job of explaining what 
would happen during the visit.   
 
2.3 “It’s just some people have the knowledge that they 
already need and don’t have a need for MTM services”: 
Patient’s Belief that MTM Services are not needed.  
  “I just felt like I had a good enough understanding 
of my medications and it wasn’t necessary.” 
 
For these participants, MTM services are mainly associated 
with a pharmacist providing information or education about 
medications. Participants did not envision the possibility of 
having a pharmacist assessing their medications and 
managing them in collaboration with their providers. These 
patients did not understand what comprehensive MTM really 
is. Several focus group participants indicated that taking more 
than two medications might be enough to make them feel 
they would benefit from meeting with an MTM pharmacist.   
 
Discussion 
The evidence from this study indicates patients are able to 
identify both the value of receiving MTM services as well as 
non-financial barriers encountered in the process of receiving 
MTM services.   
 
1. Patient-perceived Value of MTM Services 
1.1 Collaboration of the Health Care Team:  As health care 
moves more toward integrative services of interdisciplinary 
teams, it is positive patients recognize the work of the team 
as well as enjoy the advantage it offers them as patients.  As 
MTM practitioners, it is important we continue to foster 
these inter-professional relationships and allow patients to 
see the relationships in action.  If patients are not able to 
visualize the concept of teamwork in their healthcare, they 
may feel uncomfortable with receiving services such as MTM.  
Patients who want their provider to drive their healthcare 
may not seek out these services if they do not understand the 
teamwork behind the scenes.  It is important pharmacists 
providing MTM services clearly explain their role within the 
healthcare team to patients. 
 
1.2 MTM Pharmacist as Supporter/Advocate/Confidant:  As 
we continue to move forward and grow the practice of MTM, 
it is important to realize this relationship as a supporter, 
advocate, and confidant is something patients find value in 
and needs to be maintained.  Some of this may relate to the 
amount of time MTM pharmacists are often able to spend 
with patients. However, as the demand for MTM services 
grow and pharmacists are expected to become more 
efficient, time might become more limited as it is for other 
providers. As MTM services become more widespread, it is 
necessary from the patient perspective, that this source of 
relationship continues.  There will likely be a fine balance 
between maintaining this role and expanding MTM services 
to serve more patients. 
 
1.3 MTM Pharmacist as a Resource for Questions and 
Education:  It is likely not surprising to any pharmacists 
practicing MTM to find that patients see their role as a 
resource for questions and education.  It is important that we 
continue to assess the patient holistically, and not become 
the resource or expert only on one or two particular disease 
states.  Rather, we need to continue to serve the whole 
patient, acting as a resource for questions and education on a 
wide variety of topics and medications. 
 
1.4 Accessibility to the MTM Pharmacist:  This was also a 
main finding in a one-year ethnographic research conducted 
by Ramalho de Oliveira in a pharmaceutical care program.
17  
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schedules booked with patients for several weeks like other 
providers often do.  Patients enjoy having a health care 
professional they can rely on and access easily.  Interesting 
questions such as visit length and number of patients able to 
be seen in a day by an MTM pharmacist will need to be 
addressed with this in mind. 
 
1.5 Financial Benefits from Participation in MTM Services:  
As we continue to market MTM services, it may be effective 
to promote that MTM services typically decrease total cost of 
care.  While patients who work in the healthcare field might 
pay more particular attention to this, many of the focus 
group participants stated they would be more likely to 
receive MTM services if they had been aware that MTM 
services traditionally decrease total cost of care.  Participants 
also found value in having MTM as a covered benefit under 
their insurance plan, reinforcing the need to continue to push 
for more coverage of MTM services. 
 
1.6 MTM Pharmacy as a Specialty Field:  Participants felt that 
referrals and information regarding MTM services from 
providers should be handled in the same way as if they were 
seeing another physician specialist.  While it is important to 
acknowledge that patients feel MTM pharmacists are 
specialized in regards to medications, MTM pharmacists must 
also be careful not to diminish the knowledge and prescribing 
ability of physicians, but rather foster a collaborative 
approach.  MTM pharmacy as a specialty field will be 
important to discuss with providers, as patients may 
understand a referral process which resembles being referred 
to another provider. 
 
1.7 MTM Pharmacist as a Coordinator:  In some clinics, 
pharmacists may be the only non-physician provider.  As 
clinics are working toward obtaining Medical Home and 
Accountable Care Organization certification, more resources 
are being incorporated into primary care clinics.  The 
pharmacist’s role in the healthcare team continues to evolve.   
   
2.Patient-perceived Non-Financial Barriers to Receiving 
MTM Services 
2.1 Availability of the MTM Pharmacist:  Pharmacists 
providing MTM services must be cognizant of the fact that 
some patients, particularly those who work, prefer evening 
and/or weekend hours for this type of service.  Exploring 
other modes of communication for these visits, such as 
telephonic and virtual capabilities, may help eliminate some 
of these barriers to receiving MTM services. 
 
2.2 Patient/Physician Lack of Knowledge of MTM Services:  
This brings up an education point for MTM pharmacists to 
ensure that physicians in their clinic and nearby clinics can 
explain MTM services as well as an MTM pharmacist.  Time 
must be devoted to educating physicians and clinic staff to 
ensure potential patients receive an adequate description of 
the service being offered to them.  It is important that the 
person referring the patient to receive MTM services portrays 
a message explaining the potential benefits of MTM services 
and is able to answer any questions the patient may have.  
Creation of videos to explain and illustrate the process of 
receiving MTM services may be helpful for both patients and 
referral sources. 
   
2.3 Patient’s Belief MTM Services are not Needed:  We know 
that not every patient will need MTM services.  Some of the 
focus group participants may fall into that category.  As MTM 
services become more widespread, we should be able to 
gather more data to determine who really should benefit 
from MTM services.  We may be able to collect more data 
surrounding the specific reasons patients decline receiving 
MTM services through surveys and response cards sent in 
mailings.  Focusing on additional education regarding MTM 
services may help some non-participating participants 
become patients who utilize MTM services. 
 
Limitations 
There were several limitations to this study.  Many of the 
focus group participants were employees of the Fairview 
Health System, as MTM services are a covered benefit for 
them through their benefit plan.  Additionally, the focus 
group participants were a small sample size out of the total 
number of patients who have received MTM services in the 
Fairview system, and participation in the focus group sessions 
was optional. Only one focus group was held for each 
identified patient population, thus saturation was not 
reached.  
 
Conclusion 
In conclusion, patients have identified several themes of 
value regarding MTM services, and also several non-financial 
barriers that may potentially prevent them from receiving 
MTM services.  Overall, patients are satisfied with the care 
they have been receiving, but they also help us to identify 
areas for improvement.  As we continue to advance MTM 
practice, it is important to learn from their experiences and 
suggestions.  Overall, areas for improvement include 
expanding accessibility to the MTM pharmacist through 
alternative appointment modes, the need for stronger 
communication relating to the role of the MTM pharmacist in 
the healthcare team and finding more effective ways of 
explaining what MTM is and its potential value to patients 
and providers. The focus group participants have provided us 
with preliminary evidence of both the value and barriers 
perceived by patients relating to receiving MTM services. Original Research  PRACTICE-BASED RESEARCH 
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Figure 1 
 
 
Figure 1:  Research design flow for focus group recruitment.  Number of patients seen ranges from January 1997 to May 2011. 
 
 
 
 
 
 
 
Figure 2 
 
  Private Payment for MTM  Third Party Payment for 
MTM 
Non-Participating 
Average Age  62.1  57.6  52.4 
Percent Male  37.5  55.6  60.0 
 
Figure 2: Demographic information for focus group participants 
 
 
 
 
Private Payment for MTM 
1,373 patients seen by 
MTM 
50 letters mailed, 5 RSVP 
Additional 50 letters 
mailed, 5 RSVP 
8 participants attend 
Third Party Payment for 
MTM 
2,275 patients seen by 
MTM 
50 letters mailed, 10 RSVP 
No additional letters 
mailed 
9 participants attend 
Non-Participating 
9,046 patients recruited 
for MTM services 
50 letters mailed, 1 RSVP 
Additional 100 letters 
mailed, 5 RSVP 
5 participants attended 